Fundraising Fox

Aleks Radovic-Moreno

Investor

Partner at Longwood Fund

Boston, Massachusetts

Writes $100K – $5M checks Β· typically $1.5M

About

Aleks Radovic-Moreno repeatedly serves as founding or interim CEO, co-founded Be Biopharma to define engineered B cells, founded Weaver Therapeutics, and invented AST-008, which reached Phase 2.

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Experience

  1. Longwood FundPartnercurrent2019 β€” present
  2. Weaver BiosciencesCo-Founder, Founding Investor, Startup CEO, BOD Chaircurrent2024 β€” present
  3. Progentos TherapeuticsBoard Membercurrent2024 β€” present
  4. Engrail TherapeuticsBoard Observercurrent2024 β€” present
  5. Be Biopharma, Inc.Co-Founder, Founding Investor, Startup CSOcurrent2020 β€” present
  6. Tome BiosciencesCo-Founder & Founding Investor2020 β€” 2025
  7. Pyxis OncologyBoard Member2020 β€” 2021
  8. Alivio TherapeuticsCo-Founder, Founding Investor, CEO2016 β€” 2019
  9. PureTech HealthSenior Vice President2015 β€” 2019
  10. Vor BiopharmaCo-Founder, Founding Investor, COO2016 β€” 2019
  11. ExicureResearch Scientist2013 β€” 2014
  12. SR OneIntern2011

Education

  1. Massachusetts Institute of TechnologyDoctor of Philosophy (Ph.D.), Chemical and Biomedical Engineering2005 β€” 2012
  2. Harvard Medical SchoolMedical Engineering & Medical Physics Program2005 β€” 2012
  3. Penn State UniversityBachelor of Science (BS), Chemical Engineering2001 β€” 2005

Skills & more

Cell Culture9Biomedical Engineering6Research6Western BlottingMicroscopyMolecular Biology11Fluorescence MicroscopyLifesciencesNeuroscienceClinical ResearchBiotechnology13PCR
+8 moreGeneticsStatisticsScienceMedical ImagingHealthcareELISAData AnalysisConfocal Microscopy

From Aleks's professional profile.

Same school

Shared employers

Colleagues at Longwood Fund

Network6

Investors connected to Aleks in public investor directories β€” a warm-intro map.